Cell Therapy Market Trends

Growth Drivers

• Growing adoption of robotics and automation - Numerous businesses are working on robotics to automate gene and cell treatment for use in patient care since it eliminates the possibility of mistakes, variances, and contamination that come with human processing.
  
  For instance, global robot installations expanded by more than 25% in 2022, surpassing the record level reached in 2021.
• Recent launches of new cell therapies - For instance, Max Healthcare introduced chimeric antigen receptor (CAR)-T cell therapy to offer state-of-the-art care for cancer treatment, offering patients the most advanced therapeutic options.
• Increasing geriatric population - The newest alternative treatment for treating early aging is stem cell therapy by which the elderly, can feel better about themselves and have a higher quality of life, and may reverse the consequences of numerous diseases.
  
  According to the United Nations, it is anticipated that the proportion of people 65 and older in the world will increase from 10% in 2022 to 16% in 2050.

Challenges

• Lack of accessibility - At the moment, CAR T-cell therapy is one of the most expensive treatment options available worldwide owing to the high expenses associated with its administration and manufacture.
  
  This can limit its accessibility for patients living in lower economic regions.
• Safety concerns - There is no doubt that CAR T-cell treatments can cause significant harm as they may result in serious adverse effects, including infections and a mass death of B cells that produce antibodies, and dangerous adverse effect is called cytokine release syndrome (CRS).